All
Vitreous history in the making
Much has changed since the early days of vitrectomy, as exemplified in ophthalmic texts
Jetrea gets NICE reimbursement recommendation
United Kingdom’s National Institute for Health and Care Excellence (NICE) has provisionally recommended ocriplasmin (Jetrea, ThromboGenics NV) for reimbursement within the National Health Service (NHS).
Unilateral decreased vision for 2 years
What is your diagnosis?
Retina Summit to precede ARVO
The Cole Eye Institute will present a Retina Summit CME symposium immediately before the ARVO 2013 annual meeting.
Optos gets 510(k) for microperimetry
Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.
Gene therapy trials in progress
Gene therapy is making headway in inherited retinal diseases that were previously thought to be untreatable.
